Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of p... Multiple Myeloma Hub 8:51 2 years ago 21 Далее Скачать
Novel immunotherapies for the treatment of multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:15 9 years ago 64 Далее Скачать
Is treatment discontinuation feasible for patients with myeloma with deep and durable responses? VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 82 Далее Скачать
Exciting updates in ALL and the value of novel immunotherapies VJHemOnc – Video Journal of Hematology & HemOnc 1:11 1 year ago 91 Далее Скачать
Myeloma XI: early treatment stratification and novel treatment approaches VJHemOnc – Video Journal of Hematology & HemOnc 3:14 4 years ago 89 Далее Скачать
Defining and identifying ultra-high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:11 11 months ago 448 Далее Скачать
Cellular therapy: changing clinical practice for treatment of myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:28 3 years ago 79 Далее Скачать
Understanding the plasticity of elusive tumor cells to improve treatment for patients with myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:04 1 day ago 42 Далее Скачать
Is there an optimal time to deploy immunotherapies in multiple myeloma? Multiple Myeloma Hub 3:54 4 years ago 97 Далее Скачать
How do I treat patients who have relapsed after quadruplet regimen in the first-line in MM? Multiple Myeloma Hub 8:18 1 month ago 275 Далее Скачать
How to manage bridging therapies prior to CAR T cells in multiple myeloma? Multiple Myeloma Hub 3:06 2 years ago 97 Далее Скачать
Symposium | Beyond BCMA: Novel strategies using bispecific antibodies Multiple Myeloma Hub 19:00 7 months ago 184 Далее Скачать
Could radiotherapeutic approaches be a promising new treatment option for myeloma? Multiple Myeloma Hub 3:15 5 years ago 626 Далее Скачать
What are the main improvements in next-generation CAR T-cell products? Multiple Myeloma Hub 4:25 1 year ago 125 Далее Скачать
Which patients could benefit most from post-HSCT maintenance therapy with daratumumab single agent? Multiple Myeloma Hub 2:58 3 years ago 103 Далее Скачать
How the AML treatment landscape has evolved with the use of novel combination therapies VJHemOnc – Video Journal of Hematology & HemOnc 3:40 2 years ago 126 Далее Скачать
Why GPRC5D is a promising target for multiple myeloma Multiple Myeloma Hub 2:43 3 years ago 345 Далее Скачать
Novel immunotherapies for myeloma treatment VJHemOnc – Video Journal of Hematology & HemOnc 5:26 3 years ago 53 Далее Скачать
Moving beyond CAR T-cell therapy: Why is everyone talking about NK-cell therapy? Multiple Myeloma Hub 1:56 3 years ago 191 Далее Скачать
How to decide between bispecific antibodies or CAR T-cell therapies Multiple Myeloma Hub 8:31 4 years ago 283 Далее Скачать
